List of Publications

Number of articles per page 1 / 8 Articles 1 - 10 of 76
J. Fučíková, M. Podrazil, L. Jarolim, P. Bilková, M. Hensler, E. Becht, Z. Gasová, J. Kloucková, J. Kayserová, R. Horváth, A. Fialová, K. Vávrová, K. Sochorová, D. Rožková, R. Špíšek, J. Bartůňková

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Cancer Immunol Immunother. 2017 Sep 25. doi: 10.1007/s00262-017-2068-x. [Epub ahead of print]
L. Urbanová, N. Hradilová, I. Moserová, Š. Vošahliková, L. Sadílková, M. Henslera, R. Špíšek, I. Adkins

High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy.

Immunology Letters 187 (2017) 27–34
I. Adkins, L. Sadílková, N. Hradilová, J. Tomala, M. Kovář & R. Špíšek

Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Journal OncoImmunology Volume 6, 2017 - Issue 5
N. Hradilová, L. Sadilková, O. Palata, D. Mysikova, H. Mrázková, R. Lischke, R. Špíšek, I. Adkins

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.

PLOS ONE | DOI:10.1371/journal.pone.0171539
K. Dáňová, A. Grohová, P. Strnadová, D.P. Funda, Z. Šumník, J. Lebl, O. Cinek, Š. Průhová, S. Koloušková, B. Obermannová, L. Petruželková, A. Šedivá, P. Fundová, K. Buschard, R. Špíšek, L. Palová-Jelínková.

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.

J Immunol. 2017 Jan 15;198(2):729-740. doi: 10.4049/jimmunol.1600676. Epub 2016 Dec 7.
J. Fučíková, I. Truxová, M. Hensler, E. Becht, L. Kasíková, I. Moserová, S. Vošáhliková, J. Kloučková, S.E. Church, I. Cremer, O. Kepp, G. Kroemer, L. Galluzzi, C. Salek, R. Špíšek

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Blood. 2016 Dec 29;128(26):3113-3124. doi: 10.1182/blood-2016-08-731737. Epub 2016 Nov 1.
I. Truxová, M. Hensler, P. Skapa, M. J. Halaska, J. Laco, A. Ryška, R. Špíšek, J. Fučíková.

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.

Int Rev Cell Mol Biol. 2017;330:115-156. doi: 10.1016/bs.ircmb.2016.09.003. Epub 2016 Nov 29.
I. Moserová, I. Truxová, A.D. Garg, J. Tomala, P. Agostinis, P.F. Cartron, S. Vošáhlíková, M. Kovář, R. Špíšek, J. Fučíková

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

Oncoimmunology. 2016 Nov 18;6(1):e1258505. doi: 10.1080/2162402X.2016.1258505. eCollection 2017.
D. Myšíková, I. Adkins, N. Hradilová, O. Palata, J. Šimonek, J. Pozniak, J. Kolařík, A. Skallová-Fialová, R. Špíšek, R. Lischke

Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.

J Thorac Oncol. 2016 Oct 25. pii: S1556-0864(16)31176-5. doi: 10.1016/j.jtho.2016.09.136. [Epub ahead of print]
E. Vacchelli, N. Bloy, F. Aranda, A. Buqué, I. Cremer, S. Demaria, A. Eggermont, Ś.C. Formenti, W.H. Fridman, J. Fučíková, J. Galon, R. Špíšek, E. Tartour, L. Zitvogel, G. Kroemer, L. Galluzzi

Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Oncoimmunology. 2016 Jul 25;5(9):e1214790. eCollection 2016.